Revolutionary new HIV drugs are being made available in 120 low-income countries, but many important populations are being left out. Sophie Cousins reports.

ACTG is honored to share these important findings with the many global stakeholders who are gathered in Indonesia at the Union Conference,” said ACTG Chair Judith Currier, M.D., M.Sc., University of ...

The federal government yesterday formally announced the commencement of the HIV Vaccine Innovation, Science, and Technology ...

The inalienable right of every Nigerian to equitable access to quality healthcare cannot be overstated. A firm believer in ...

With Novo Nordisk’s patent on semaglutide set to expire in India, Dr Reddy’s is among the forerunners trying to bring the ...

Spread This NewsBy Nqoba M Sibenke We painted the sky pink in honour of Breast Cancer Awareness Month. In the streets, you ...

Spread This News BBC As it became clear that Donald Trump had landed the US presidency for the second time, leaders from across Africa began tweeting their congratulations. “Zimbabwe stands ready to ...

From Bettina Bauer, Vice President, US HIV Treatment and Prevention, Gilead Sciences In 2022, there were up to 1.2 million ...

Gilead (GILD) reported positive results from a pivotal Phase 3 study of its twice-yearly HIV prevention treatment lenacapavir ...

A virologist at the University of Nebraska-Lincoln, Qingsheng Li, was awarded $3.5 million to advance his work on a vaccine ...

HIV is an infection that can be transmitted from one person to another through sexual activity, such as anal, oral, or vaginal sex. The terms “sexually transmitted infections (STIs)” and ...